Stay updated on Amifampridine in MuSK-MG Clinical Trial
Sign up to get notified when there's something new on the Amifampridine in MuSK-MG Clinical Trial page.

Latest updates to the Amifampridine in MuSK-MG Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.1%
- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedThe page has been updated to include new information about Myasthenia Gravis and a new version revision, while significant details regarding a clinical study on amifampridine phosphate have been removed.SummaryDifference25%
- Check29 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.1%
- Check66 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference2%
- Check87 days agoChange DetectedThe web page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.SummaryDifference2%
- Check94 days agoChange DetectedThe website has been updated from version 2.14.1 to 2.14.2.SummaryDifference0.1%
Stay in the know with updates to Amifampridine in MuSK-MG Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Amifampridine in MuSK-MG Clinical Trial page.